KHEIRON® Spinal Fixation System, including patient specific K-ROD

K262828 · S.M.A.I.O · NKB · Sep 4, 2026 · Orthopedic

Device Facts

Record IDK262828
Device NameKHEIRON® Spinal Fixation System, including patient specific K-ROD
ApplicantS.M.A.I.O
Product CodeNKB · Orthopedic
Decision DateSep 4, 2026
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3070
Device ClassClass 2
AttributesTherapeutic, Pediatric

Indications for Use

KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion.When used for posterior, non-cervical, pedicle screw fixation in pediatric patients, KHEIRON® Spinal Fixation System including patient specific K-ROD is indicated as an adjunct to fusion to treat progressive spinal deformities (i.e., scoliosis, kyphosis, or lordosis) including idiopathic scoliosis, neuromuscular scoliosis, and congenital scoliosis. Additionally, KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to treat pediatric patients diagnosed with spondylolisthesis/spondylolysis, fracture caused by tumor and/or trauma, pseudarthrosis, and/or failed previous fusion.This system is intended to be used with autograft and/or allograft.Pediatric pedicle screw fixation is limited to a posterior approach.When connected to compatible pedicle screw systems, the patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion.Please refer to the additional information section of the most up-to-date Instructions for Use on compatible pedicle screw systems.

Device Story

Patient-specific spinal rod (K-ROD) component of KHEIRON® Spinal Fixation System; provides immobilization/stabilization of thoracic, lumbar, and sacral spine segments as adjunct to fusion. Device manufactured from Ti-6Al-4V ELI (ASTM F136) or Co-28Cr-6Mo (ASTM F1537). Modification expands compatibility of K-ROD with third-party pedicle screw systems (Silony VERTICALE®, Orthofix Mariner, Highridge Vital, DePuy Synthes Expedium/TriAltis, Orthofix Virata). Used by surgeons in clinical settings to maintain spinal alignment/shape until fusion occurs. Output is mechanical stabilization of spinal segments.

Clinical Evidence

Bench testing only. Mechanical verification performed per ASTM F1717 (dynamic compression) and ASTM F1798 (static axial/torsional gripping capacity). Results confirm mechanical strength is equivalent to primary predicate devices.

Technological Characteristics

Materials: Ti-6Al-4V ELI (ASTM F136) or Co-28Cr-6Mo (ASTM F1537). Form factor: Patient-specific spinal rods, 5.5mm and 6.0mm diameters. Mechanical fixation via pedicle screw system interface. Sterilization: Not specified. Connectivity: N/A (mechanical implant).

Indications for Use

Indicated for skeletally mature patients with acute/chronic spinal instabilities or deformities (DDD, spondylolisthesis, fracture, dislocation, scoliosis, kyphosis, lordosis, stenosis, tumor, pseudarthrosis, failed fusion). Also indicated for pediatric patients (posterior approach only) for progressive spinal deformities (idiopathic, neuromuscular, congenital scoliosis), spondylolisthesis/spondylolysis, fracture, pseudarthrosis, and failed fusion.

Regulatory Classification

Identification

(1) Rigid pedicle screw systems are comprised of multiple components, made from a variety of materials that allow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. Such a spinal implant assembly consists of a combination of screws, longitudinal members (e.g., plates, rods including dual diameter rods, plate/rod combinations), transverse or cross connectors, and interconnection mechanisms (e.g., rod-to-rod connectors, offset connectors).(2) Semi-rigid systems are defined as systems that contain one or more of the following features (including but not limited to): Non-uniform longitudinal elements, or features that allow more motion or flexibility compared to rigid systems.

Special Controls

*Classification.* (1) Class II (special controls), when intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). These pedicle screw spinal systems must comply with the following special controls:(i) Compliance with material standards; (ii) Compliance with mechanical testing standards; (iii) Compliance with biocompatibility standards; and (iv) Labeling that contains these two statements in addition to other appropriate labeling information: “Warning: The safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the thoracic, lumbar, and sacral spine secondary to severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra, degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other conditions are unknown.” “Precaution: The implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.” (2) Class II (special controls), when a rigid pedicle screw system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion in the treatment of degenerative disc disease and spondylolisthesis other than either severe spondylolisthesis (grades 3 and 4) at L5-S1 or degenerative spondylolisthesis with objective evidence of neurologic impairment. These pedicle screw systems must comply with the following special controls: (i) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use. (ii) Non-clinical performance testing must demonstrate the mechanical function and durability of the implant. (iii) Device components must be demonstrated to be biocompatible. (iv) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments. (v) Labeling must include the following: (A) A clear description of the technological features of the device including identification of device materials and the principles of device operation; (B) Intended use and indications for use, including levels of fixation; (C) Identification of magnetic resonance (MR) compatibility status; (D) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user; and (E) Detailed instructions of each surgical step, including device removal. (3) Class II (special controls), when a semi-rigid system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion for any indication. In addition to complying with the special controls in paragraphs (b)(2)(i) through (v) of this section, these pedicle screw systems must comply with the following special controls: (i) Demonstration that clinical performance characteristics of the device support the intended use of the product, including assessment of fusion compared to a clinically acceptable fusion rate. (ii) Semi-rigid systems marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with the special controls in paragraphs (b)(2)(i) through (v) and paragraph (b)(3)(i) of this section.

Predicate Devices

Submission Summary (Full Text)

{0} **FDA** U.S. FOOD & DRUG ADMINISTRATION September 4, 2026 S.M.A.I.O % Robert A. Poggie President BioVera, Inc. 65 Promenade Saint Louis Notre-Dame-De-L'Île-Perrot, QC J7W 3J6 Canada Re: K262828 Trade/Device Name: KHEIRON® Spinal Fixation System, including patient specific K-ROD Regulation Number: 21 CFR 888.3070 Regulation Name: Thoracolumbosacral pedicle screw system Regulatory Class: Class II Product Code: NKB, KWP Dated: August 10, 2026 Received: August 10, 2026 Dear Robert A. Poggie: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K262828 - Robert A. Poggie Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See {2} K262828 - Robert A. Poggie Page 3 the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, COLIN O'NEILL -S Colin O'Neill, M.B.E. Assistant Director DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K262828 | ? | | Please provide the device trade name(s). | | ? | | KHEIRON® Spinal Fixation System, including patient specific K-ROD | | | | Please provide your Indications for Use below. | | ? | | KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion.When used for posterior, non-cervical, pedicle screw fixation in pediatric patients, KHEIRON® Spinal Fixation System including patient specific K-ROD is indicated as an adjunct to fusion to treat progressive spinal deformities (i.e., scoliosis, kyphosis, or lordosis) including idiopathic scoliosis, neuromuscular scoliosis, and congenital scoliosis. Additionally, KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to treat pediatric patients diagnosed with spondylolisthesis/spondylolysis, fracture caused by tumor and/or trauma, pseudarthrosis, and/or failed previous fusion.This system is intended to be used with autograft and/or allograft.Pediatric pedicle screw fixation is limited to a posterior approach.When connected to compatible pedicle screw systems, the patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion.Please refer to the additional information section of the most up-to-date Instructions for Use on compatible pedicle screw systems. | | | | Please select the types of uses. | Prescription Use (21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C) | ? | | Please select the age group(s) for which the device(s) is to be used. | Neonates/Newborns (Birth to < 29 days old)Infants (29 days old to < 2 years old)Children (2 years old to < 12 years old)Adolescents (12 years old to < 22 years old)Adults (22 years old and greater) | ? | {4} K262828- Page 1 of 4 510(k) #: # 510(k) Summary Prepared on: 2026-09-04 Contact Details 21 CFR 807.92(a)(1) | Applicant Name | S.M.A.I.O | | --- | --- | | Applicant Address | 2 place Berthe Morisot Saint-Priest 69800 France | | Applicant Contact Telephone | +33670165171 | | Applicant Contact | Mr. Jean-Charles Roussouly | | Applicant Contact Email | jc.roussouly@smaio.com | | Correspondent Name | BioVera, Inc. | | Correspondent Address | 65 Promenade Saint Louis Notre-Dame-de-L'Ile-Perrot QC J7W3J6 United States | | Correspondent Contact Telephone | (514) 349-7226 | | Correspondent Contact | Dr. Robert A. Poggie | | Correspondent Contact Email | orthobob@biovera.ca | Device Name 21 CFR 807.92(a)(2) | Device Trade Name | KHEIRON® Spinal Fixation System, including patient specific K-ROD | | --- | --- | | Common Name | Thoracolumbosacral pedicle screw system | | Classification Name | Thoracolumbosacral Pedicle Screw System | | Regulation Number | 888.3070 | | Product Code(s) | NKB, KWP | Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) | Predicate # | Predicate Trade Name (Primary Predicate is listed first) | Product Code | | --- | --- | --- | | K211981 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | | K253802 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | | K171421 | VERTICALE® Posterior Spinal Fixation System/VERTICALE® System | NKB | | K222110 | Mariner RDX System | NKB | | K251804 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | {5} K262828- Page 2 of 4 | K240539 | Vital™ Spinal Fixation System | NKB | | --- | --- | --- | | K253721 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | | K200245 | EXPEDIUM® Spine System; EXPEDIUM VERSE® Spine System | NKB | | K231479 | TriALTIS Spine System | NKB | | K253990 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | | K250908 | Virata Spinal Fixation System | NKB | | K260786 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | | K232650 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | NKB | ## Device Description Summary 21 CFR 807.92(a)(4) S.M.A.I.O.'s patient specific K-ROD is part of the 510(k) cleared KHEIRON® Spinal Fixation system (K211981, K232650, K251804, K253721, K253802, K253990, K260786) designed for stabilization and correction of chronic instability or deformity of the thoracic, lumbar, and sacral spine. The patient specific K-ROD is manufactured from Ti-6Al-4V ELI per ASTM F136 or Co-28Cr-6Mo per ASTM 1537 and is available in diameters of 5.5 and 6.0 mm. The Ti-6Al-4V ELI patient-specific K-ROD was cleared under K211981 and has subsequently been cleared for use with the NuVasive Reline System under K232650, the Orthofix Mariner System under K251804, the Highridge Vital System under K253721, the DePuy Synthes Expedium and TriAltis Systems under K253990, and the Orthofix Virata System under K260786. The Co-28Cr-6Mo patient-specific K-ROD, as an extension of the KHEIRON® Spinal Fixation System, was cleared under K253802. The Silony VERTICALE® System is a 510(k) cleared pedicle screw system (K171421) that consists of a variety of screws, hooks, rods, lock screws, transverse connectors, rod-to-rod connectors, iliac connectors, and general instruments. Implant components are available in a variety of sizes and can be rigidly locked into a variety of different configurations to suit the individual pathology and anatomical conditions of the patient. The Silony VERTICALE® System is designed to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine. The VERTICALE® System is intended for non-cervical pedicle fixation and nonpedicle fixation for the following indications: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); spinal stenosis; curvatures (i.e., scoliosis, kyphosis, and/or lordosis); tumor, pseudoarthrosis; and failed previous fusion in skeletally mature patients. The purpose of this Special 510(k) Device Modification is: 1-To add the compatibility of the Co-28Cr-6Mo patient-specific K-ROD, cleared under K253802, with the Orthofix Mariner System (K222110), the Highridge Vital System (K240539), the DePuy Synthes Expedium and TriAltis Systems (K200245 and K231479), and the Orthofix Virata System (K250908), for which compatibility with the Ti-6Al-4V ELI patient-specific K-ROD was previously cleared under K251804, K253721, K253990, and K260786, respectively. 2-To extend indication of S.M.A.I.O.'s Ti-6Al-4V and Co-28Cr-6Mo patient specific K-ROD (K211981, K232650, K251804, K253721, K253802, K253990, K260786) for use with the Silony VERTICALE® System (K171421). ## Intended Use/Indications for Use 21 CFR 807.92(a)(5) KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion. {6} K262828- Page 3 of 4 When used for posterior, non-cervical, pedicle screw fixation in pediatric patients, KHEIRON® Spinal Fixation System including patient specific K-ROD is indicated as an adjunct to fusion to treat progressive spinal deformities (i.e., scoliosis, kyphosis, or lordosis) including idiopathic scoliosis, neuromuscular scoliosis, and congenital scoliosis. Additionally, KHEIRON® Spinal Fixation System including patient specific K-ROD is intended to treat pediatric patients diagnosed with spondylolisthesis/spondylolysis, fracture caused by tumor and/or trauma, pseudarthrosis, and/or failed previous fusion. This system is intended to be used with autograft and/or allograft. Pediatric pedicle screw fixation is limited to a posterior approach. When connected to compatible pedicle screw systems, the patient specific K-ROD is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), spinal stenosis, spinal tumor, pseudarthrosis and failed previous fusion. Please refer to the additional information section of the most up-to-date Instructions for Use on compatible pedicle screw systems. ## Indications for Use Comparison 21 CFR 807.92(a)(5) The indications for use of the subject device are identical to those of the predicate devices, except for the addition of compatibility with the Silony VERTICALE® System (K171421) and the addition of compatibility of the Co-28Cr-6Mo patient-specific K-ROD with spinal fixation systems for which compatibility with the Ti-6Al-4V ELI patient-specific K-ROD was previously established. More specifically, the Ti-6Al-4V ELI patient-specific K-ROD was cleared under K211981 and compatibility with the following spinal fixation systems was subsequently established: the NuVasive Reline System under K232650, the Orthofix Mariner System under K251804, the Highridge Vital System under K253721, the DePuy Synthes Expedium and TriAltis Systems under K253990, and the Orthofix Virata Spinal Fixation System under K260786. The Co-28Cr-6Mo patient-specific K-ROD was cleared under K253802. This 510(k) establishes compatibility of the Co-28Cr-6Mo patient-specific K-ROD with the Orthofix Mariner System (K222110), the Highridge Vital System (K240539), the DePuy Synthes Expedium and TriAltis Systems (K200245 and K231479), and the Orthofix Virata Spinal Fixation System (K250908), as well as compatibility of both the Ti-6Al-4V ELI and Co-28Cr-6Mo patient-specific K-RODs with the Silony VERTICALE® System (K171421). ## Technological Comparison 21 CFR 807.92(a)(6) The patient specific K-ROD subject device is identical to the patient specific K-ROD cleared in K211981, K232650, K251804, K253721, K253802, K253990 and K260786. The components of the Silony VERTICALE® System that interface with the patient specific K-ROD are identical to those cleared in K171421. The components of the Orthofix Mariner System, Highridge Vital System, DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System that interface with the patient-specific K-ROD are identical to the corresponding components cleared under K222110, K253093, K222473 and K253249, and K250908, respectively. The purpose of this Special 510(k) is to summarize in DCAS format the V&V activities demonstrating that the Ti-6Al-4V and Co-28Cr-6Mo K-ROD can be used with the Silony VERTICALE® System and that the Co-28Cr-6Mo patient-specific K-ROD can be used with the applicable components of the Orthofix Mariner, Highridge Vital, DePuy Synthes Expedium and TriAltis, and Orthofix Virata spinal fixation systems. For the compatibility of the Ti-6Al-4V and Co-28Cr-6Mo K-ROD and the Silony VERTICALE® System: Intended Use: K-RODs used in conjunction with the Silony VERTICALE® System, and the predicate devices are intended to be used to maintain spine shape until fusion occurs. Indications for Use: The indications for use statement for the primary predicate and subject devices are the same. Material: K-RODs used in conjunction with the Silony VERTICALE® System uses the same material as the predicates (ASTM F136 Ti-6Al-4V alloy or ASTM 1537 Co-28Cr-6Mo). The manufacturing processes, including cleaning and passivation, are the same for the titanium alloy and CoCrMo alloy K-RODs per the referenced 510K clearances. Design: K-RODs used in conjunction with the Silony VERTICALE® System and the predicate devices are substantially equivalent in shape, sizes, material, and manufacturing process. Strength: K-ROD used with the Silony VERTICALE® System has similar strength as the primary predicate K-ROD per verification and validation activities summarized later herein in DCAS table format. For the compatibility of the Co-28Cr-6Mo patient-specific K-ROD with the Orthofix Mariner System, Highridge Vital System, DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System: Intended Use: The Co-28Cr-6Mo patient-specific K-ROD used in conjunction with the Orthofix Mariner System, Highridge Vital System, {7} K262828- Page 4 of 4 DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System, and the corresponding predicate devices, are intended to maintain spinal alignment until fusion occurs. Indications for Use: The indications for use statements for the subject device and the corresponding predicate devices are the same. Material: The Co-28Cr-6Mo patient-specific K-ROD used in conjunction with the Orthofix Mariner System, Highridge Vital System, DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System is manufactured from Co-28Cr-6Mo conforming to ASTM F1537, consistent with the patient-specific K-ROD cleared under K253802. Materials and manufacturing processes remain the same as cleared in K253802, K253721, K253990, and K260786. Design: The Co-28Cr-6Mo patient-specific K-ROD used in conjunction with the Orthofix Mariner System, Highridge Vital System, DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System and the corresponding predicate devices are substantially equivalent in shape, sizes, material, and manufacturing process. Strength: The Co-28Cr-6Mo patient-specific K-ROD used with the Orthofix Mariner System, Highridge Vital System, DePuy Synthes Expedium and TriAltis Systems, and Orthofix Virata Spinal Fixation System has similar strength as the primary predicate K-ROD per verification and validation activities summarized later herein in DCAS table format. ## Non-Clinical and/or Clinical Tests Summary & Conclusions 21 CFR 807.92(b) Engineering analysis and mechanical testing of Ti-6Al-4V K-RODs used with the Silony VERTICALE® System were performed to verify and validate the mechanical characteristics of the expanded use of patient specific K-RODs. The following mechanical tests were performed as part of the V&V activities: - Dynamic compression – ASTM F1717 - Static axial gripping capacity – ASTM F1798 - Static torsional gripping capacity – ASTM F1798 The ASTM F1717 and F1798 tests performed for V&V of K-ROD used with the Silony VERTICALE® System were identical in set-up and test parameters as presented in K211981. Engineering analysis comparing K-ROD and Silony VERTICALE® System's titanium alloy rods determined that a new worst-case was not created for the K-ROD used with the Silony VERTICALE® System relative to the primary predicate K-ROD (K211981) and predicate Silony VERTICALE® System (K171421) devices. Mechanical testing of Co-28Cr-Mo K-RODs (K253802) used with the Orthofix Mariner System (K222110), the Highridge Vital System (K240539), the DePuy Synthes Expedium and TriAltis Systems (K200245 and K231479), and the Orthofix Virata System (K250908), for which compatibility with the Ti-6Al-4V ELI patient-specific K-ROD was previously cleared under K251804, K253721, K253990, and K260786, respectively, and with the Silony VERTICALE® System (K171421) were performed to verify and validate the mechanical characteristics of the expanded use of patient specific CoCrMo alloy K-RODs. The following mechanical tests were performed as part of the V&V activities: - Static axial gripping capacity – ASTM F1798 - Static torsional gripping capacity – ASTM F1798 The ASTM F1798 tests performed for V&V of CoCrMo K-ROD used with the above listed company systems were identical in set-up and test parameters as presented in K253802. The results of testing showed no new worst case relative to that presented in K253802. The information presented in this Special 510(k) Device Modification demonstrates that the KHEIRON® Spinal Fixation System, including patient specific K-ROD, is compatible with the Spinal Systems described in this 510(k) and is substantially equivalent to the legally marketed predicate devices.
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...